Table 2.
Multivariate analysis of SNORA38 expression and clinical pathology factor.
| Factors | Number | SNORA38 expression | P | Crude OR (95 CI) | |
|---|---|---|---|---|---|
| (%) | High (%) | Low (%) | |||
| Tumor size | |||||
| ≥ 3 cm | 43 (55.8) | 24 (55.8) | 19 (44.2) | 0.022 | 4.669 (1.249 - 17.448) |
| < 3 cm | 34 (44.2) | 9 (26.5) | 25 (73.5) | Reference | |
| LN Metastases | |||||
| Negative | 53 (68.8) | 17 (32.1) | 36 (67.9) | Reference | |
| Positive | 24 (31.2) | 16 (66.7) | 8 (33.3) | 0.057 | 3.591 (0.962 - 13.411) |
| ER | |||||
| Negative | 22 (28.6) | 5 (22.7) | 17 (77.3) | Reference | |
| Positive | 55 (71.4) | 28 (50.9) | 27 (49.1) | 0.065 | 3.374 (0.926 - 12.295) |
| TNM staging | |||||
| I | 25 (32.5) | 8 (32.0) | 17 (68.0) | Reference | |
| II | 45 (58.4) | 19 (42.2) | 26 (57.8) | 0.199 | 2.656 (0.599 - 11.782) |
| III | 7 (9.1) | 6 (85.7) | 1 (14.3) | 0.667 | 0.547 (0.035 - 8.517) |